323 related articles for article (PubMed ID: 16941521)
1. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.
Suominen E; Toivonen R; Grenman R; Savontaus M
J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521
[TBL] [Abstract][Full Text] [Related]
2. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
3. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.
Toivonen R; Suominen E; Grenman R; Savontaus M
Oncol Rep; 2009 Jan; 21(1):165-71. PubMed ID: 19082458
[TBL] [Abstract][Full Text] [Related]
4. Novel adenoviral gene delivery system targeted against head and neck cancer.
Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
[TBL] [Abstract][Full Text] [Related]
5. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
[TBL] [Abstract][Full Text] [Related]
6. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
Rocco JW; Li D; Liggett WH; Duan L; Saunders JK; Sidransky D; O'Malley BW
Clin Cancer Res; 1998 Jul; 4(7):1697-704. PubMed ID: 9676844
[TBL] [Abstract][Full Text] [Related]
7. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
8. FasL gene therapy: a new therapeutic modality for head and neck cancer.
ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
Lalonde ES; Beyer G; Friedlander PL; Kolls JK
Head Neck; 2002 Dec; 24(12):1038-46. PubMed ID: 12454941
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
12. Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases.
Shayakhmetov DM; Li ZY; Ni S; Lieber A
Cancer Res; 2002 Feb; 62(4):1063-8. PubMed ID: 11861383
[TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
[TBL] [Abstract][Full Text] [Related]
14. Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses.
Bonsted A; Engesaeter BØ; Høgset A; Maelandsmo GM; Prasmickaite L; Kaalhus O; Berg K
Gene Ther; 2004 Jan; 11(2):152-60. PubMed ID: 14712299
[TBL] [Abstract][Full Text] [Related]
15. Coxsackie adenovirus receptor and alpha nu beta3/alpha nu beta5 integrins in adenovirus gene transfer of rat cochlea.
Venail F; Wang J; Ruel J; Ballana E; Rebillard G; Eybalin M; Arbones M; Bosch A; Puel JL
Gene Ther; 2007 Jan; 14(1):30-7. PubMed ID: 16886000
[TBL] [Abstract][Full Text] [Related]
16. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta.
Brüning A; Runnebaum IB
Gene Ther; 2003 Feb; 10(3):198-205. PubMed ID: 12571626
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
Kim SY; Yang YS; Hong KH; Jang KY; Chung MJ; Lee DY; Lee JC; Yi HK; Nam SY; Hwang PH
Oral Oncol; 2008 Apr; 44(4):383-92. PubMed ID: 17690006
[TBL] [Abstract][Full Text] [Related]
18. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
Parks R; Evelegh C; Graham F
Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
[TBL] [Abstract][Full Text] [Related]
19. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
20. Efficient infection of tumor endothelial cells by a capsid-modified adenovirus.
Shinozaki K; Suominen E; Carrick F; Sauter B; Kähäri VM; Lieber A; Woo SL; Savontaus M
Gene Ther; 2006 Jan; 13(1):52-9. PubMed ID: 16107861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
